{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T06:22:44Z","timestamp":1791699764003,"version":"4.3.4"},"reference-count":80,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Society of Cytopathology"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.jasc.2020.06.011","type":"journal-article","created":{"date-parts":[[2020,7,17]],"date-time":"2020-07-17T12:10:29Z","timestamp":1594987829000},"page":"29-35","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"title":["A review of urinary cytology in the setting of upper tract urothelial carcinoma"],"prefix":"10.1016","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8029-4787","authenticated-orcid":false,"given":"M. Lisa","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8822-5655","authenticated-orcid":false,"given":"Christopher J.","family":"VandenBussche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4299-2784","authenticated-orcid":false,"given":"Jen-Fan","family":"Hang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7331-0382","authenticated-orcid":false,"given":"Yurina","family":"Miki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick J.","family":"McIntire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Peyton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6055-4465","authenticated-orcid":false,"given":"Poonam","family":"Vohra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jasc.2020.06.011_bib1","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1097\/PAP.0b013e31817145a9","article-title":"Neoplasms of the upper urinary tract: a review with focus on urothelial carcinoma of the pelvicalyceal system and aspects related to its diagnosis and reporting","volume":"15","author":"Gupta","year":"2008","journal-title":"Adv Anat Pathol"},{"key":"10.1016\/j.jasc.2020.06.011_bib2","first-page":"7","article-title":"Cancer statistics, 2020","volume":"70","author":"Siegel","year":"2020","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.jasc.2020.06.011_bib3","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.eururo.2017.07.036","article-title":"European Association of Urology guidelines on upper urinary tract urothelial carcinoma: 2017 update","volume":"73","author":"Roupr\u00eat","year":"2018","journal-title":"Eur Urol"},{"key":"10.1016\/j.jasc.2020.06.011_bib4","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1002\/cncr.24135","article-title":"Outcomes of radical nephroureterectomy: a series from the Upper Tract Urothelial Carcinoma Collaboration","volume":"115","author":"Margulis","year":"2009","journal-title":"Cancer"},{"key":"10.1016\/j.jasc.2020.06.011_bib5","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.urology.2016.10.055","article-title":"Detection of upper tract urothelial malignancies by computed tomography urography in patients referred for hematuria at a large tertiary referral center","volume":"102","author":"Commander","year":"2017","journal-title":"Urology"},{"key":"10.1016\/j.jasc.2020.06.011_bib6","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1111\/j.1464-410X.2010.09899.x","article-title":"Urinary cytology has a poor performance for predicting invasive or high-grade upper-tract urothelial carcinoma","volume":"108","author":"Messer","year":"2011","journal-title":"BJU Int"},{"key":"10.1016\/j.jasc.2020.06.011_bib7","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/S0090-4295(01)01182-7","article-title":"Detection of upper urinary tract transitional cell carcinoma with ImmunoCyt: a preliminary report","volume":"58","author":"Lodde","year":"2001","journal-title":"Urology"},{"key":"10.1016\/j.jasc.2020.06.011_bib8","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/S0090-4295(01)01307-3","article-title":"The BTA stat test: a tumor marker for the detection of upper tract transitional cell carcinoma","volume":"58","author":"Walsh","year":"2001","journal-title":"Urology"},{"key":"10.1016\/j.jasc.2020.06.011_bib9","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.urology.2016.04.030","article-title":"Diagnostic utility of selective upper tract urinary cytology: a systematic review and meta-analysis of the literature","volume":"96","author":"Potretzke","year":"2016","journal-title":"Urology"},{"key":"10.1016\/j.jasc.2020.06.011_bib10","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1309\/HC0U-8MEL-9GGV-G9EW","article-title":"Transitional cell carcinoma of the renal pelvis the diagnostic role of pelvic washings","volume":"117","author":"Witte","year":"2002","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.jasc.2020.06.011_bib11","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1016\/j.eururo.2015.07.039","article-title":"Genomic characterization of upper tract urothelial carcinoma","volume":"68","author":"Sfakianos","year":"2015","journal-title":"Eur Urol"},{"key":"10.1016\/j.jasc.2020.06.011_bib12","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1016\/j.juro.2016.01.006","article-title":"Genomic biomarkers for the prediction of stage and prognosis of upper tract urothelial carcinoma","volume":"195","author":"Bagrodia","year":"2016","journal-title":"J Urol"},{"key":"10.1016\/j.jasc.2020.06.011_bib13","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/j.eururo.2017.05.048","article-title":"Comprehensive genomic characterization of upper tract urothelial carcinoma","volume":"72","author":"Moss","year":"2017","journal-title":"Eur Urol"},{"key":"10.1016\/j.jasc.2020.06.011_bib14","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.tranon.2017.10.008","article-title":"Molecular characterization of urothelial carcinoma of the bladder and upper urinary tract","volume":"11","author":"Lee","year":"2018","journal-title":"Transl Oncol"},{"key":"10.1016\/j.jasc.2020.06.011_bib15","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1158\/1078-0432.CCR-18-2039","article-title":"Clonal relatedness and mutational differences between upper tract and bladder urothelial carcinoma","volume":"25","author":"Audenet","year":"2019","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jasc.2020.06.011_bib16","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1111\/j.1464-410X.2009.08838.x","article-title":"Environmental factors involved in carcinogenesis of urothelial cell carcinomas of the upper urinary tract","volume":"104","author":"Colin","year":"2009","journal-title":"BJU Int"},{"key":"10.1016\/j.jasc.2020.06.011_bib17","doi-asserted-by":"crossref","first-page":"8241","DOI":"10.1073\/pnas.1119920109","article-title":"Aristolochic acid-associated urothelial cancer in Taiwan","volume":"109","author":"Chen","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jasc.2020.06.011_bib18","doi-asserted-by":"crossref","first-page":"197ra102","DOI":"10.1126\/scitranslmed.3006200","article-title":"Mutational signature of aristolochic acid exposure as revealed by whole-exome sequencing","volume":"5","author":"Hoang","year":"2013","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.jasc.2020.06.011_bib19","doi-asserted-by":"crossref","first-page":"197ra101","DOI":"10.1126\/scitranslmed.3006086","article-title":"Genome-wide mutational signatures of aristolochic acid and its application as a screening tool","volume":"5","author":"Poon","year":"2013","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.jasc.2020.06.011_bib20","doi-asserted-by":"crossref","first-page":"e32143","DOI":"10.7554\/eLife.32143","article-title":"Non-invasive detection of urothelial cancer through the analysis of driver gene mutations and aneuploidy","volume":"7","author":"Springer","year":"2018","journal-title":"eLife"},{"key":"10.1016\/j.jasc.2020.06.011_bib21","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1111\/cas.14000","article-title":"Diagnostic potential of TERT promoter and FGFR3 mutations in urinary cell-free DNA in upper tract urothelial carcinoma","volume":"110","author":"Hayashi","year":"2019","journal-title":"Cancer Sci"},{"key":"10.1016\/j.jasc.2020.06.011_bib22","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/s00428-016-2001-2","article-title":"High prevalence of TERT promoter mutations in micropapillary urothelial carcinoma","volume":"469","author":"Nguyen","year":"2016","journal-title":"Virchows Arch"},{"key":"10.1016\/j.jasc.2020.06.011_bib23","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1038\/modpathol.2016.53","article-title":"High prevalence of TERT promoter mutations in primary squamous cell carcinoma of the urinary bladder","volume":"29","author":"Cowan","year":"2016","journal-title":"Mod Pathol"},{"key":"10.1016\/j.jasc.2020.06.011_bib24","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.humpath.2016.02.009","article-title":"Detection of TERT promoter mutations in primary adenocarcinoma of the urinary bladder","volume":"53","author":"Cowan","year":"2016","journal-title":"Hum Pathol"},{"key":"10.1016\/j.jasc.2020.06.011_bib25","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/s00428-019-02654-1","article-title":"Performance of novel non-invasive urine assay UroSEEK in cohorts of equivocal urine cytology","volume":"476","author":"Rodriguez Pena","year":"2020","journal-title":"Virchows Arch"},{"key":"10.1016\/j.jasc.2020.06.011_bib27","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.urolonc.2017.05.009","article-title":"Optimizing management of upper tract urothelial carcinoma","volume":"35","author":"Campbell","year":"2017","journal-title":"Urol Oncol"},{"key":"10.1016\/j.jasc.2020.06.011_bib28","doi-asserted-by":"crossref","DOI":"10.1177\/1756287218815372","article-title":"Contemporary best practice in the management of urothelial carcinomas of the renal pelvis and ureter","volume":"11","author":"Bianconi","year":"2019","journal-title":"Ther Adv Urol"},{"key":"10.1016\/j.jasc.2020.06.011_bib29","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1007\/s11864-019-0637-2","article-title":"Optimal management of upper tract urothelial carcinoma: an unmet need","volume":"20","author":"Azizi","year":"2019","journal-title":"Curr Treat Options Oncol"},{"key":"10.1016\/j.jasc.2020.06.011_bib30","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1007\/s00345-018-02624-3","article-title":"Impact of intravesical therapy for non-muscle invasive bladder cancer on the accuracy of urine cytology","volume":"37","author":"Gupta","year":"2019","journal-title":"World J Urol"},{"key":"10.1016\/j.jasc.2020.06.011_bib31","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1111\/cyt.12538","article-title":"Urinary cytology and the Paris system for reporting urinary cytology: implications for urological management","volume":"29","author":"Gupta","year":"2018","journal-title":"Cytopathology"},{"key":"10.1016\/j.jasc.2020.06.011_bib32","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/0090-4295(82)90601-X","article-title":"Transitional cell carcinoma of renal pelvis","volume":"19","author":"Nocks","year":"1982","journal-title":"Urology"},{"key":"10.1016\/j.jasc.2020.06.011_bib33","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/S0090-4295(99)00563-4","article-title":"Risk factors for the development of bladder cancer after upper tract urothelial cancer","volume":"55","author":"Hisataki","year":"2000","journal-title":"Urology"},{"key":"10.1016\/j.jasc.2020.06.011_bib34","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/S0302-2838(02)00370-6","article-title":"Laparoscopic radical nephroureterectomy: results of an international multicenter study","volume":"42","author":"El Fettouh","year":"2002","journal-title":"Eur Urol"},{"key":"10.1016\/j.jasc.2020.06.011_bib35","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1046\/j.1464-410x.2000.00888.x","article-title":"The long-term outcome after laparoscopic nephroureterectomy: a comparison with open nephroureterectomy","volume":"86","author":"McNeill","year":"2000","journal-title":"BJU Int"},{"key":"10.1016\/j.jasc.2020.06.011_bib36","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1089\/end.2015.0137","article-title":"A comparison of 30-day perioperative outcomes in open versus minimally invasive nephroureterectomy for upper tract urothelial carcinoma: analysis of 896 patients from the American College of Surgeons\u2013National Surgical Quality Improvement Program Database","volume":"29","author":"Hanske","year":"2015","journal-title":"J Endourol"},{"key":"10.1016\/j.jasc.2020.06.011_bib37","doi-asserted-by":"crossref","first-page":"27.e1","DOI":"10.1016\/j.urolonc.2012.09.011","article-title":"Is the performance of urinary cytology as high as reported historically? A contemporary analysis in the detection and surveillance of bladder cancer","volume":"32","author":"Yafi","year":"2014","journal-title":"Urol Oncol"},{"key":"10.1016\/j.jasc.2020.06.011_bib38","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s00345-016-1820-8","article-title":"Investigating upper urinary tract urothelial carcinomas: a single-centre 10-year experience","volume":"35","author":"Dev","year":"2017","journal-title":"World J Urol"},{"key":"10.1016\/j.jasc.2020.06.011_bib39","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1002\/dc.23746","article-title":"Upper urinary tract washings outperform voided urine specimens to detect upper tract high-grade urothelial carcinoma","volume":"45","author":"Zhang","year":"2017","journal-title":"Diagn Cytopathol"},{"key":"10.1016\/j.jasc.2020.06.011_bib40","first-page":"101","article-title":"Upper urinary tract washing in the diagnosis of transitional cell carcinoma of the renal pelvis and calices: a comparison with voided urine","volume":"41","author":"Raica","year":"1995","journal-title":"Rom J Morphol Embryol"},{"key":"10.1016\/j.jasc.2020.06.011_bib41","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.jasc.2014.09.203","article-title":"Diagnosis of upper tract urothelial carcinoma\u2014a comparative study of urinary cytology and surgical biopsy","volume":"4","author":"Wang","year":"2015","journal-title":"J Am Soc Cytopathol"},{"key":"10.1016\/j.jasc.2020.06.011_bib42","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1002\/cncy.21278","article-title":"Evaluation of atypical urine cytology progression to malignancy","volume":"121","author":"Muus Ubago","year":"2013","journal-title":"Cancer Cytopathol"},{"key":"10.1016\/j.jasc.2020.06.011_bib43","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1007\/s10147-015-0817-4","article-title":"Fluorodeoxyglucose positron emission tomography\/computed tomography for diagnosis of upper urinary tract urothelial carcinoma","volume":"20","author":"Asai","year":"2015","journal-title":"Int J Clin Oncol"},{"key":"10.1016\/j.jasc.2020.06.011_bib44","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1159\/000330246","article-title":"Diagnostic value of the nuclear matrix protein 22 test and urine cytology in upper tract urothelial tumors","volume":"87","author":"Jovanovic","year":"2011","journal-title":"Urol Int"},{"key":"10.1016\/j.jasc.2020.06.011_bib45","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1046\/j.1464-410x.2000.00830.x","article-title":"The clinical implications of telomerase activity in upper tract urothelial cancer and washings","volume":"86","author":"Wu","year":"2000","journal-title":"BJU Int"},{"key":"10.1016\/j.jasc.2020.06.011_bib46","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1159\/000332528","article-title":"Endoscopic brush cytology of the upper urinary tract: evaluation of its efficacy and potential limitations in diagnosis","volume":"41","author":"Dodd","year":"1997","journal-title":"Acta Cytol"},{"key":"10.1016\/j.jasc.2020.06.011_bib47","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1002\/cncy.21971","article-title":"When words matter: a \u201csuspicious\u201d urinary tract cytology diagnosis improves patient follow-up among nonurologists","volume":"126","author":"Fite","year":"2018","journal-title":"Cancer Cytopathol"},{"key":"10.1016\/j.jasc.2020.06.011_bib48","doi-asserted-by":"crossref","first-page":"5823870","DOI":"10.1155\/2018\/5823870","article-title":"Performance of urinary markers for detection of upper tract urothelial carcinoma: is upper tract urine more accurate than urine from the bladder?","volume":"2018","author":"Bier","year":"2018","journal-title":"Dis Markers"},{"key":"10.1016\/j.jasc.2020.06.011_bib49","first-page":"1754","article-title":"A comparative analysis of rapid urine tests for the diagnosis of upper urinary tract malignancy","volume":"10","author":"Siemens","year":"2003","journal-title":"Can J Urol"},{"key":"10.1016\/j.jasc.2020.06.011_bib50","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1002\/dc.23878","article-title":"The Paris system for reporting urinary cytology improves correlation with surgical pathology biopsy diagnoses of the lower urinary tract","volume":"46","author":"Bertsch","year":"2018","journal-title":"Diagn Cytopathol"},{"key":"10.1016\/j.jasc.2020.06.011_bib51","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.jasc.2018.07.006","article-title":"Utility of The Paris System for reporting urinary cytology in upper urinary tract specimens","volume":"7","author":"Xing","year":"2018","journal-title":"J Am Soc Cytopathol"},{"key":"10.1016\/j.jasc.2020.06.011_bib52","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1002\/cncy.22034","article-title":"Improved diagnostic precision of urine cytology by implementation of The Paris System and the use of cell blocks","volume":"126","author":"Chan","year":"2018","journal-title":"Cancer Cytopathol"},{"key":"10.1016\/j.jasc.2020.06.011_bib53","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.jasc.2018.11.001","article-title":"Cell block preparation in urine cytology: examination of utility and workflow in an academic practice","volume":"8","author":"Dantey","year":"2019","journal-title":"J Am Soc Cytopathol"},{"key":"10.1016\/j.jasc.2020.06.011_bib54","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1111\/cyt.12580","article-title":"Clinical and cytopathological factors affecting the cellularity of urinary cell blocks and the implication for diagnosis and follow-up of urinary bladder urothelial carcinoma","volume":"29","author":"Brisuda","year":"2018","journal-title":"Cytopathology"},{"key":"10.1016\/j.jasc.2020.06.011_bib55","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1002\/cncy.21634","article-title":"Adequacy in voided urine cytology specimens: the role of volume and a repeat void upon predictive values for high-grade urothelial carcinoma","volume":"124","author":"VandenBussche","year":"2016","journal-title":"Cancer Cytopathol"},{"key":"10.1016\/j.jasc.2020.06.011_bib56","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.jasc.2017.04.001","article-title":"Adequacy of voided urine specimens prepared by ThinPrep and evaluated using The Paris System for reporting urinary cytology","volume":"6","author":"Rezaee","year":"2017","journal-title":"J Am Soc Cytopathol"},{"key":"10.1016\/j.jasc.2020.06.011_bib57","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1002\/cncy.22090","article-title":"Adequacy criteria for voided urine cytology using Cytospin preparations","volume":"127","author":"Renshaw","year":"2019","journal-title":"Cancer Cytopathol"},{"key":"10.1016\/j.jasc.2020.06.011_bib58","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jasc.2014.09.206","article-title":"Evidence-based adequacy criteria for urinary bladder barbotage cytology","volume":"4","author":"Prather","year":"2015","journal-title":"J Am Soc Cytopathol"},{"key":"10.1016\/j.jasc.2020.06.011_bib59","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1002\/cncy.21634","article-title":"A minimum volume of 30 mL is necessary to ensure that a voided urine specimen is benign: a retrospective review of 15,731 cases","volume":"124","author":"VandenBussche","year":"2016","journal-title":"Cancer Cytopathol"},{"key":"10.1016\/j.jasc.2020.06.011_bib60","series-title":"The Paris System for Reporting Urinary Cytology","year":"2016"},{"key":"10.1016\/j.jasc.2020.06.011_bib61","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1111\/cyt.12345","article-title":"A review of the Paris system for reporting urinary cytology","volume":"27","author":"VandenBussche","year":"2016","journal-title":"Cytopathology"},{"key":"10.1016\/j.jasc.2020.06.011_bib62","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1002\/cncy.22006","article-title":"A 20-year and 46,000-specimen journey to Paris reveals the influence of reporting systems and passive peer feedback on pathologist practice patterns","volume":"126","author":"VandenBussche","year":"2018","journal-title":"Cancer Cytopathol"},{"key":"10.1016\/j.jasc.2020.06.011_bib63","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.jasc.2018.04.001","article-title":"The Paris System for reporting urinary cytology: early review of the literature reveals successes and rare shortcomings","volume":"7","author":"Cowan","year":"2018","journal-title":"J Am Soc Cytopathol"},{"key":"10.1016\/j.jasc.2020.06.011_bib64","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.humpath.2018.11.021","article-title":"Clinical utility and concordance of upper urinary tract cytology and biopsy in predicting clinicopathological features of upper urinary tract urothelial carcinoma","volume":"86","author":"Simon","year":"2019","journal-title":"Hum Pathol"},{"key":"10.1016\/j.jasc.2020.06.011_bib65","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1002\/dc.24127","article-title":"The utility of upper urinary tract urine cytology before and after application of the Paris system","volume":"47","author":"Simon","year":"2019","journal-title":"Diagn Cytopathol"},{"key":"10.1016\/j.jasc.2020.06.011_bib66","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1111\/cyt.12505","article-title":"The Paris System for urine cytology in upper tract urothelial specimens: a comparative analysis with biopsy and surgical resection","volume":"29","author":"Zheng","year":"2018","journal-title":"Cytopathology"},{"key":"10.1016\/j.jasc.2020.06.011_bib67","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1002\/cncy.22005","article-title":"Improved correlation of urinary cytology specimens using The Paris System in biopsy-proven upper tract urothelial carcinomas","volume":"126","author":"McIntire","year":"2018","journal-title":"Cancer Cytopathol"},{"key":"10.1016\/j.jasc.2020.06.011_bib68","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1093\/ajcp\/aqy170","article-title":"Diagnostic utility of UroVysion combined with conventional urinary cytology for urothelial carcinoma of the upper urinary tract","volume":"151","author":"Sassa","year":"2019","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.jasc.2020.06.011_bib69","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1002\/cncy.21843","article-title":"Improved risk stratification for patients with high-grade urothelial carcinoma following application of the Paris system for reporting urinary cytology","volume":"125","author":"Cowan","year":"2017","journal-title":"Cancer Cytopathol"},{"key":"10.1016\/j.jasc.2020.06.011_bib70","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1002\/cncy.21254","article-title":"The Johns Hopkins Hospital template for urologic cytology samples: parts II and III: improving the predictability of indeterminate results in urinary cytologic samples: an outcomes and cytomorphologic study","volume":"121","author":"VandenBussche","year":"2013","journal-title":"Cancer Cytopathol"},{"key":"10.1016\/j.jasc.2020.06.011_bib71","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1002\/cncy.21883","article-title":"Digital image analysis supports a nuclear-to-cytoplasmic ratio cutoff value of 0.5 for atypical urothelial cells","volume":"125","author":"Hang","year":"2017","journal-title":"Cancer Cytopathol"},{"key":"10.1016\/j.jasc.2020.06.011_bib72","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.jasc.2018.02.005","article-title":"Paris interobserver reproducibility study (PIRST)","volume":"7","author":"Kurtycz","year":"2018","journal-title":"J Am Soc Cytopathol"},{"key":"10.1016\/j.jasc.2020.06.011_bib73","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1002\/cncy.21735","article-title":"Morphologists overestimate the nuclear-to-cytoplasmic ratio","volume":"124","author":"Zhang","year":"2016","journal-title":"Cancer Cytopathol"},{"key":"10.1016\/j.jasc.2020.06.011_bib74","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1002\/dc.23767","article-title":"Urinary tract washing specimens containing atypical urothelial tissue fragments are significantly associated with urothelial neoplasia","volume":"45","author":"Zhang","year":"2017","journal-title":"Diagn Cytopathol"},{"key":"10.1016\/j.jasc.2020.06.011_bib75","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1002\/cncy.21501","article-title":"Benign-appearing urothelial tissue fragments in noninstrumented voided urine specimens are associated with low rates of urothelial neoplasia","volume":"123","author":"Onur","year":"2015","journal-title":"Cancer Cytopathol"},{"key":"10.1016\/j.jasc.2020.06.011_bib76","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1002\/cncy.21519","article-title":"Atypical urothelial tissue fragments in noninstrumented voided urine specimens are associated with low but significantly higher rates of urothelial neoplasia than benign-appearing urothelial tissue fragments","volume":"123","author":"Onur","year":"2015","journal-title":"Cancer Cytopathol"},{"key":"10.1016\/j.jasc.2020.06.011_bib77","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1007\/s11255-014-0714-1","article-title":"FISH analysis of washing urine from the upper urinary tract for the detection of urothelial cancers","volume":"46","author":"Gruschwitz","year":"2014","journal-title":"Int Urol Nephrol"},{"key":"10.1016\/j.jasc.2020.06.011_bib78","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.urology.2010.07.498","article-title":"Utility of a modality combining FISH and cytology in upper tract urothelial carcinoma detection in voided urine samples of Chinese patients","volume":"77","author":"Xu","year":"2011","journal-title":"Urology"},{"key":"10.1016\/j.jasc.2020.06.011_bib79","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/j.urology.2007.06.1103","article-title":"Fluorescence in situ hybridization for detecting upper urinary tract tumors\u2014a preliminary report","volume":"70","author":"Akkad","year":"2007","journal-title":"Urology"},{"key":"10.1016\/j.jasc.2020.06.011_bib80","doi-asserted-by":"crossref","first-page":"183","DOI":"10.3892\/ol.2016.4592","article-title":"Prospective evaluation of FISH for detecting upper tract urothelial carcinoma in voided urine specimens","volume":"12","author":"Yu","year":"2016","journal-title":"Oncol Lett"},{"key":"10.1016\/j.jasc.2020.06.011_bib81","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/j.juro.2010.05.023","article-title":"Voided urine fluorescence in situ hybridization testing for upper tract urothelial carcinoma surveillance","volume":"184","author":"Johannes","year":"2010","journal-title":"J Urol"}],"container-title":["Journal of the American Society of Cytopathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213294520301307?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213294520301307?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T06:46:28Z","timestamp":1761979588000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213294520301307"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":80,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["S2213294520301307"],"URL":"https:\/\/doi.org\/10.1016\/j.jasc.2020.06.011","relation":{},"ISSN":["2213-2945"],"issn-type":[{"value":"2213-2945","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A review of urinary cytology in the setting of upper tract urothelial carcinoma","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Society of Cytopathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jasc.2020.06.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc. on behalf of American Society of Cytopathology.","name":"copyright","label":"Copyright"}]}}